The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Plasma Concentrations of Cystatin C in Patients with Coronary Heart Disease and Risk for Secondary Cardiovascular Events: More than Simply a Marker of Glomerular Filtration Rate
Abstract
Background: Renal impairment (RI) is associated with worse prognosis. Recently, cystatin C has been shown to represent a potentially superior marker of the glomerular filtration rate compared with creatinine clearance (CrCl). We evaluated the impact of cystatin C and other markers of RI on prognosis in a large cohort of patients with coronary heart disease (CHD). Methods: Cystatin C, creatinine (Cr), and CrCl were determined at baseline in a cohort of 1033 patients (30–70 years) with CHD. Patients were followed for a mean of 33.5 months, and a combined endpoint [fatal and nonfatal cardiovascular disease (CVD) events] was used as the outcome variable. Cystatin C was measured by immunonephelometry, and CrCl was calculated. Results: During follow-up, 71 patients (6.9%) experienced a secondary CVD event. Neither Cr (P = 0.63) nor CrCl (P = 0.10) were associated with incidence of CVD events, whereas cystatin C was clearly associated with risk of secondary CVD events (P <0.0001). In multivariate analyses, patients in the top quintile of the cystatin C distribution at baseline had a statistically significantly increased risk of secondary CVD events even after adjustment for classic risk factors, severity of coronary disease, history of diabetes mellitus, treatment with angiotensin-converting enzyme inhibitors, and C-reactive protein (hazard ratio, 2.27; 95% confidence interval, 1.05–4.91) compared with patients in the bottom quintile. Conclusions: These data support the possibly important prognostic value of cystatin C among patients with known CHD and suggest that it may be a useful clinical marker providing complementary information to established risk determinants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Mann, J. F. E., Gerstein, H. C., Pogue, J., Bosch, J., Yusuf, S., & for the HOPE Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00007 · Cited by 1,372
Limitations of creatinine as a filtration marker in glomerulopathic patients
Shemesh, O., Golbetz, H., Kriss, J. P., & Myers, B. D. (1985) · Kidney International · doi:10.1038/ki.1985.205 · Cited by 1,227
Knight, E. L., Verhave, J. C., Spiegelman, D., Hillege, H. L., De Zeeuw, D., Curhan, G. C., & De Jong, P. E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00517.x · Cited by 1,039
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency
Shlipak, M. G., Fried, L. F., Crump, C., Bleyer, A. J., Manolio, T. A., Tracy, R. P., Furberg, C. D., & Psaty, B. M. (2003) · Circulation · doi:10.1161/01.cir.0000042700.48769.59 · Cited by 810
McAlister, F. A., Ezekowitz, J., Tonelli, M., & Armstrong, P. W. (2004) · Circulation · doi:10.1161/01.cir.0000116764.53225.a9 · Cited by 702
Newman, D. J., Thakkar, H., Edwards, R. G., Wilkie, M., White, T., Grubb, A. O., & Price, C. P. (1995) · Kidney International · doi:10.1038/ki.1995.40 · Cited by 650
Coresh, J., Wei, G. L., McQuillan, G., Brancati, F. L., Levey, A. S., Jones, C., & Klag, M. J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1207 · Cited by 587
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals
Fried, L. F., Shlipak, M. G., Crump, C., Kronmal, R. A., Bleyer, A. J., Gottdiener, J. S., Kuller, L. H., & Newman, A. B. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00163-3 · Cited by 535
Kyhse-Andersen, J., Schmidt, C., Nordin, G., Andersson, B., Nilsson-Ehle, P., Lindström, V, & Grubb, A. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.10.1921 · Cited by 511
Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes
Al Suwaidi, J., Reddan, D. N., Williams, K., Pieper, K. S., Harrington, R. A., Califf, R. M., Granger, C. B., Ohman, E. M., & Holmes, D. R. (2002) · Circulation · doi:10.1161/01.cir.0000027560.41358.b3 · Cited by 479
Renal handling of radiolabelled human cystatin C in the rat
Tenstad, O., Roald, A. B., Grubb, A., & Aukland, K. (1996) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519609088795 · Cited by 456
Sadeghi, H. M., Stone, G. W., Grines, C. L., Mehran, R., Dixon, S. R., Lansky, A. J., Fahy, M., Cox, D. A., Garcia, E., Tcheng, J. E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103623.63687.21 · Cited by 403
Gibson, C. M., Pinto, D. S., Murphy, S. A., Morrow, D. A., Hobbach, H.-P., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., & Braunwald, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.06.001 · Cited by 285
OBRADOR, G. T., RUTHAZER, R., ARORA, P., KAUSZ, A. T., & PEREIRA, B. J. G. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1081793 · Cited by 244
Junge, W., Wilke, B., Halabi, A., & Klein, G. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.02.007 · Cited by 241
Newman, D. J. (2002) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/0004563021901847 · Cited by 215
Levey, A. S., Coresh, J., Balk, E. M., Kausz, A. T., Levin, A., & Steffes, M. W. (2003) · Annals of Internal Medicine · Cited by 195
Freeman, R. V., Mehta, R. H., Al Badr, W., Cooper, J. V., Kline-Rogers, E., & Eagle, K. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02956-x · Cited by 175
McClellan, W. M., Knight, D. F., Karp, H. R., & Brown, W. W. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90197-9 · Cited by 172
Szekanecz, Z., Shah, M. R., Pearce, W. H., & Koch, A. E. (1994) · Inflammation Research · doi:10.1007/bf01983484 · Cited by 161
Determination of Serum Cystatin C: Biological Variation and Reference Values
Galteau, M.-M., Guyon, M., Gueguen, R., & Siest, G. (2001) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2001.141 · Cited by 159
Woitas, R. P., Stoffel‐Wagner, B., Flommersfeld, S., Pöge, U., Schiedermaier, P., Klehr, H., Spengler, U., BIDLINGMAIER, F., & Sauerbruch, T. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.5.712 · Cited by 137
The Search Continues—An Ideal Marker of GFR
Swan, S. K. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.6.913 · Cited by 133
Štabuc, B., Vrhovec, L., Šilih, M. Š., & Cizej, T. E. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.2.193 · Cited by 132
Eriksson, P. O., Deguchi, H., Samnegård, A., Lundman, P., Boquist, S., Tornvall, P., Ericsson, C.-G., Bergstrand, L., Hansson, L., Ye, S., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000117180.57731.36 · Cited by 108
Neutrophil chemotactic activity is modulated by human cystatin C, an inhibitor of cysteine proteases
Leung-Tack, J., Tavera, C., Martínez, J., & Collé, A. (1990) · Inflammation · doi:10.1007/bf00915809 · Cited by 71
Albert, M. A., Rifai, N., & Ridker, P. M. (2001) · Vascular Medicine · doi:10.1177/1358836x0100600304 · Cited by 38
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Metadata
- Authors
- Koenig, W., Twardella, D., Brenner, H., & Rothenbacher, D.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-02-01
- Volume
- 51
- Issue
- 2
- Pages
- 321-327
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W1991198324
- Cited by
- 296
- References
- 30
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.